On January 6, 2021, the U.S. Patent & Trademark Office
issued a memorandum to the Patent Trial and Appeal Board, requiring
that, in post-grant trial proceedings, the Board must follow the
same indefiniteness standard used in district courts. The
Board must now analyze indefiniteness in post-grant trial
proceedings under the standard set forth in Nautilus, Inc.
v. Biosig Instruments, Inc., 572 U.S. 898 (2014)—that
is, a claim is indefinite if, read in light of the specification
and the prosecution history, it fails to inform those skilled in
the art about the scope of invention with reasonable
certainty. Id. at 901.
For many years, the Office and Board had used a different
indefiniteness standard, approved by the Federal Circuit
in In re Packard, 751 F.3d 1307 (Fed. Cir. 2014) (per
curiam). Under the Packard standard, a
claim was indefinite “when it contains words or phrases whose
meaning is unclear.” Id. at 1310,
1314.